ANTI-ANGIOGENIC EffiCACY OF AflIBERCEPT AND BEVACIZUMAB IN PRIMARY ORAL SQUAMOUS CELL CARCINOMA CELLS

作者: Mr. Meysam Ganjibakhsh , Dr. Roshanak Monshizadeh , Mr. Ahmad Nasimian , Dr. Pouyan Aminishakib , Dr. Parvaneh Farzaneh

DOI: 10.1016/J.OOOO.2019.02.162

关键词: Cell growthCellSecretionLungMedicineAfliberceptCell migrationCancer researchVascular endothelial growth factorBevacizumab

摘要: … The anti-angiogenic activity of both bevacizumab and aflibercept has been researched on … of metastatic colorectal cancer (mCRC) patients in 2004 as the first anti-angiogenic-targeted …

参考文章(0)